Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes
J. Clin. Invest. Jehonathan H. Pinthus, et al. 114:1774
doi:10.1172/JCI22284 [Go to this article.]

Problems with a PDF?